Grifols (GRFS) Total Debt (2009 - 2025)
Grifols (GRFS) posted Total Debt of $10.6 billion for Q4 2025, up 4.34% quarter-over-quarter from $10.1 billion in Q4 2024, and up 4.34% year-on-year from $10.1 billion in Q4 2024.
Grifols (GRFS) Total Debt (2009 - 2025) Analysis & Trends
Grifols (GRFS) has reported Total Debt for 16 consecutive years, with $10.6 billion the latest figure, recorded in Q4 2025.
- Total Debt for Q4 2025 came in at $10.6 billion, up 4.34% year-over-year; the trailing twelve-month figure through Dec 2025 was $10.6 billion (up 4.34% YoY), and the FY2025 annual result was $10.6 billion, up 4.34% from the prior year.
- Total Debt was $10.6 billion for Q4 2025 at Grifols, up from $10.1 billion in the prior quarter.
- Over five years, Total Debt peaked at $10.6 billion in Q4 2025 and troughed at $1.0 billion in Q4 2023.
- Average Total Debt over 5 years is $8.2 billion, with a median of $10.1 billion recorded in 2024.
- Year-over-year, Total Debt tumbled 90.38% in 2023 and soared 913.97% in 2024.
- Over 5 years, Total Debt stood at $8.9 billion in 2021, then increased by 16.31% to $10.4 billion in 2022, then sank by 90.38% to $1.0 billion in 2023, then jumped by 913.97% to $10.1 billion in 2024, then climbed by 4.34% to $10.6 billion in 2025.
- Per Business Quant data, the three most recent Total Debt figures were $10.6 billion in Q4 2025, $10.1 billion in Q4 2024, and $1.0 billion in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 43.37 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 54.99 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 64.53 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -24.45 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 49.12 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 57.32 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 22.17 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 64.46 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | -19.00 Mn |
| 10 | Grifols | - | - | - | 10.58 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.58 Bn |
| Dec 31, 2024 | 10.14 Bn |
| Dec 31, 2023 | 1.00 Bn |
| Dec 31, 2022 | 10.39 Bn |
| Dec 31, 2021 | 8.94 Bn |
| Dec 31, 2020 | 8.38 Bn |
| Dec 31, 2019 | 112.62 Mn |
| Dec 31, 2018 | 108.68 Mn |
| Dec 31, 2017 | 6.97 Bn |
| Dec 31, 2016 | 61.65 Mn |
| Dec 31, 2015 | 5.33 Bn |
| Dec 31, 2014 | 5.44 Bn |
| Dec 31, 2013 | 3.83 Bn |
| Sep 30, 2013 | 3.64 Bn |
| Jun 30, 2013 | 3.68 Bn |
| Mar 31, 2013 | 3.76 Bn |
| Dec 31, 2012 | 3.74 Bn |
| Sep 30, 2012 | 3.58 Bn |
| Jun 30, 2012 | 3.73 Bn |
| Mar 31, 2012 | 3.57 Bn |